A Phase 3 interventional study of TOMs of Maine Sensitive SLS Free Xtra Fresh and Colgate Cavity protection toothpaste in Sensitivity, Tooth, sponsored by Colgate Palmolive. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-05.
Sponsored by Colgate Palmolive · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Dentin Sensitivity with a site in United States — 5 open to participants now, 7 under way, none of them phase 3. Dentin Sensitivity · United States.
Among the 57 studies in Dentin Sensitivity with a site in United States, this one is the 36th largest by enrollment of the 54 interventional ones that give a count, is one of 6 that started in 2025, is one of 8 in phase 3, and was the 49th registered.
290 studies on the registry are indexed under Dentin Sensitivity; 47 are open to participants now.
Browse Dentin Sensitivity studies →5 of the 57 studies in Dentin Sensitivity with a site in United States are open now. Recruiting first, the newest first:
Indiana University · Sites in United States
Ages 18+
HALEON · Sites in United States
Ages 18+ · Healthy volunteers
University of Pittsburgh · Sites in United States
Ages 18–65
American Academy of Facial Esthetics · Sites in United States
Ages 20–70
University of Oklahoma · Sites in United States
Ages 18–65 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 18 Dentin Sensitivity studies recruiting now, 6 (33%) set no upper age limit and 11 (61%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 6 started in 2025.
This study's enrollment of 84 is above the median of 60 across 280 interventional studies indexed under Dentin Sensitivity.
Median enrollment 120 across the 54 interventional studies, 1,036 across the 3 observational. Of the 50 that completed or were terminated, 40 (80%) have results posted.
This tab as a report to print or save as PDF → With an account.
49 of 57 have an industry lead sponsor. The 10 most frequent:
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
Colgate Palmolive has 7 studies filed under Dentin Sensitivity — fewer than ten, so there is no comparison to draw.
4 of the studies in Dentin Sensitivity with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07300540HALEONReal-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief | 2026-11 |
| NCT07337109HALEONA Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers | 2027-02 |
| NCT07590960University of PittsburghModified Coronally Advanced Tunnel for Mandibular Lingual Root Coverage | 2027-07 |
| NCT07195357Indiana UniversityMulti-site Study to Look at Tooth Wear and Tooth Sensitivity and the Risk Factors Associated. | 2027-10 |
Add all 4 to your calendar (.ics) → With an account.
Among the 57 studies in Dentin Sensitivity with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The objective of this clinical investigation is to assess the efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York, NY, USA) in the reduction of dentinal hypersensitivity over an eight (8) week period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
During this clinical study, you will be assigned to one of the two study groups. You will be provided with a toothpaste and toothbrush for at home use. You will be instructed to brush your teeth twice daily for one (1) minute each time. You are to repeat the same procedures for the duration of the study.
Device: TOMs of Maine Sensitive SLS Free Xtra Fresh
During this clinical study, you will be assigned to one of the two study groups. You will be provided with a toothpaste and toothbrush for at home use. You will be instructed to brush your teeth twice daily for two (2) minute each time. You are to repeat the same procedures for the duration of the study.
Drug: Colgate Cavity protection toothpaste
Cover the entire length of bristled head with toothpaste. Brush your teeth twice daily (morning and evening) for one (1) minute each time. For investigational use only by the study participant. Not for Sale.
Cover the entire length of bristled head with toothpaste. Brush your teeth twice daily (morning and evening) for (2) two minutes each time. For investigational use only by the study participant.
Tactile stimulation by the Yeaple Probe
Hypersensitivity defined by a response score in the range of 10-50 grams of force.
Time frame: baseline, 3 day, 4 weeks, 8 weeks
Air blast stimulation
Jet of air delivered by a standard dental unit syringe at a measured temperature of 19-21°C (70°F \[± 3°F\]) \[hypersensitivity defined by a response score of 2 or 3 on the Schiff Cold Air Sensitivity Scale
Time frame: baseline, 3 day, 4 weeks, 8 weeks
Ran from Aug 2025 to primary completion in Oct 2025, 1 month.
Of 13 phase 3 interventional studies under Dentin Sensitivity, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 14. This study's 1 month is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Fluorophosphate